Pancreatic Cancer Research

ResearcherDemocritus University of ThraceActive in the last 2 years

Stylianos Kakolyris

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5113764494. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
8
Papers, trials and grants by year

2011: 1 paper · 2012: 2 papers · 2013: none · 2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 5

  1. Prognostic significance of BRCA1 and BRCA2 methylation status in circulating cell-free DNA of Pancreatic Cancer patients. Last author DOI 10.7150/jca.93184↗
  2. Current and future intratumoral targeted treatment for pancreatic cancer. Co-author DOI 10.4155/tde.14.44↗
  3. Docetaxel plus gemcitabine in combination with capecitabine as treatment for inoperable pancreatic cancer: a phase II study. Last author DOI 10.1007/s00280-011-1717-6↗
  4. Preliminary results of hyperthermic intraperitoneal intraoperative chemotherapy as an adjuvant in resectable pancreatic cancer. Co-author DOI 10.1155/2012/506571↗
  5. Molecular pathogenesis of pancreatic cancer and clinical perspectives. Last author DOI 10.1159/000334449↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Paul Zarogoulidis · 3 shared papers, 2011–2024 · strength 0.26
  2. Dimitrios Matthaios · 2 shared papers, 2011–2024 · strength 0.22
  3. Anastasios J. Karayiannakis · 1 shared paper, 2024 · strength 0.19
  4. Triantafyllia Koukaki · 1 shared paper, 2024 · strength 0.19
  5. Antonios-Apostolos K. Tentes · 2 shared papers, 2012 · strength 0.06
  6. Panos Prasopoulos · 1 shared paper, 2012 · strength 0.03
  7. Nicolaos Courcoutsakis · 1 shared paper, 2012 · strength 0.03
  8. Nikolaos Xenidis · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.